比利时弗兰德斯地区先天性巨细胞病毒筛查频率多中心回顾性研究

数据集获取（Figshare）

• 源站标题：Screening frequency for congenital cytomegalovirus in Flanders, Belgium – a multicentre retrospective study
• DOI：10.6084/m9.figshare.28533800.v1
• 发布日期：2025-03-04
• 文件数：7 个
• 文件总体积：5.73 MB
• 源站页面：https://tandf.figshare.com/articles/dataset/Screening_frequency_for_congenital_cytomegalovirus_in_Flanders_Belgium_a_multicentre_retrospective_study/28533800

命令行下载

curl -L -o "yacb_a_2465674_sm9252.docx" "https://ndownloader.figshare.com/files/52788926"
curl -L -o "yacb_a_2465674_sm5353.docx" "https://ndownloader.figshare.com/files/52788929"
curl -L -o "yacb_a_2465674_sm5352.docx" "https://ndownloader.figshare.com/files/52788935"
curl -L -o "yacb_a_2465674_sm5351.jpg" "https://ndownloader.figshare.com/files/52788938"
curl -L -o "yacb_a_2465674_sm5350.jpg" "https://ndownloader.figshare.com/files/52788941"
curl -L -o "yacb_a_2465674_sm5349.jpg" "https://ndownloader.figshare.com/files/52788944"
curl -L -o "yacb_a_2465674_sm5348.jpg" "https://ndownloader.figshare.com/files/52788947"

文件清单

• yacb_a_2465674_sm9252.docx（5.33 MB）
• yacb_a_2465674_sm5353.docx（35.51 KB）
• yacb_a_2465674_sm5352.docx（36.59 KB）
• yacb_a_2465674_sm5351.jpg（46.42 KB）
• yacb_a_2465674_sm5350.jpg（44.23 KB）
• yacb_a_2465674_sm5349.jpg（52.69 KB）
• yacb_a_2465674_sm5348.jpg（190.08 KB）

文件总体积 5.73 MB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

This study investigates the screening practices for congenital cytomegalovirus (cCMV) in Flanders, Belgium, with the aim of determining the frequency of neonatal screening and the number of diagnoses resulting from it.
Flemish hospitals with maternity facilities were asked for data on the number of infants screened for cCMV (PCR-CMV on saliva or urine), and diagnosed with cCMV (positive PCR-CMV on urine before the age of 3 weeks). Screening and diagnosis rates were compared across geographic regions and screening policies. We defined that at least 3% of neonates should be screened, given the prevalence of common screening indications (i.e. microcephaly and IUGR), and evaluated whether the empirical incidence of cCMV (0.5%) was approached.
Fifty of 57 eligible hospitals participated. Overall, 1.65% of infants were screened and 0.12% were diagnosed with cCMV. Few hospitals screened 3% or more of infants (14/50), and measured an incidence of 0.5% or more (6/50). Hospitals using targeted screening policies conducted fewer screenings (median 1.5% vs 94.2%, p p There was important variability in cCMV screening practices across Flanders. Most hospitals screened fewer than 3% of infants, i.e. lower than the prevalence of microcephaly, a clinical feature that warrants testing for cCMV. Failure to diagnose cCMV in a timely manner limits the opportunities for early treatment with valganciclovir (secondary prevention) and morbidities such as hearing loss (tertiary prevention). There is a pressing need to enhance the knowledge and vigilance of perinatal healthcare professionals in Flanders, ensuring infants at risk of cCMV are appropriately identified and receive timely care.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.28533800.v1（source: https://tandf.figshare.com/articles/dataset/Screening_frequency_for_congenital_cytomegalovirus_in_Flanders_Belgium_a_multicentre_retrospective_study/28533800）。